EDIT Snapshot
Editas Medicine, Inc., a clinical-stage genome editing company, is focused on developing transformative genomic drugs to treat a variety of serious diseases. The company is headquartered in Cambridge, Massachusetts.
VALUATION DATA
Market Capitalization$605,831,000
Price to Sales9.00
Earnings per Share$-2.0200
PE RatioNone
PRICE DATA
Most Recent Close$7.4200
52 Week High$7.81
52 Week Low$1.692
50-Day Moving Average$3.893
200-Day Moving Average$-1.864
All data are from Alpha Vantage as of today. For more infomation on EDIT see Stock Dividend, Valuation, Price and Financial Data for Investors